Condition: Scleroderma · Mildly Elevated Pulmonary Pressures · Sponsor: Johns Hopkins University
This is a Phase II randomized, double-blind, placebo-controlled trial of sildenafil in men and women with Scleroderma with mildly elevated pulmonary pressures (SSc-MEP) to determine whether sildenafil may be an effective treatment for SSc-MEP.
This description comes directly from the study's public registry record.
Stephen Mathai, MD · 4106146311 · smathai4@jhmi.edu
Renee Ofori · 410-614-6311 · rofori2@jhu.edu
Always discuss trial participation with your own doctor first.
| Louisiana State University | New Orleans, Louisiana, United States | Not Yet Recruiting |
| Johns Hopkins | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04797286